925252-42-2 Usage
Description
N'-Hydroxy-2-(2-thienyl)ethanimidamide, a chemical compound with the molecular formula C6H7NOS, is a derivative of thienyl that features an imidamide group and a hydroxyl group. N'-HYDROXY-2-(2-THIENYL)ETHANIMIDAMIDE holds potential in medicinal chemistry and drug development due to its unique structural features, which may confer biological activity. As a relatively new compound, N'-Hydroxy-2-(2-thienyl)ethanimidamide requires further research to fully elucidate its properties and explore its potential applications.
Uses
Used in Pharmaceutical Industry:
N'-Hydroxy-2-(2-thienyl)ethanimidamide is used as a compound in drug development for its potential medicinal properties. The presence of the thienyl group and imidamide group may contribute to its biological activity, making it a candidate for the creation of new pharmaceuticals.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, N'-Hydroxy-2-(2-thienyl)ethanimidamide serves as a subject of study to understand its interactions with biological systems. Its structural components could provide insights into the design of new drugs with specific therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 925252-42-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,2,5 and 2 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 925252-42:
(8*9)+(7*2)+(6*5)+(5*2)+(4*5)+(3*2)+(2*4)+(1*2)=162
162 % 10 = 2
So 925252-42-2 is a valid CAS Registry Number.
925252-42-2Relevant articles and documents
Aryl imidazole derivative and application thereof
-
Paragraph 0116-0119, (2021/06/23)
The invention relates to an aryl imidazole derivative and application thereof. The aryl imidazole derivative is a compound shown as a formula (I) in the description or pharmaceutically acceptable salt thereof. The invention also discloses application of the aryl imidazole derivative in preparation of drugs for treating cancers. The invention further discloses application of the aryl imidazole derivative in preparation of drugs for treating diseases caused by EGFR mutation.
3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
-
, (2008/06/13)
The invention provides aminoalkylindole compounds of Formula (I), wherein R1-R5, n and p are as described. Also provided are compositions containing compounds of Formula (I) and the use of compounds of Formula (I) in modulating the activity of a cannabinoid receptor in a subject. In particular, the invention provides the use of such compounds as analgesic agents.
